MedPath

Establishment of new amniotic fluid biomarkers that reflect the short- and long-term prognosis of fetal growth restriction childre

Not Applicable
Recruiting
Conditions
fetal growth restriction
Registration Number
JPRN-UMIN000052569
Lead Sponsor
Shiga University of Medical Science Department of Obstetrics and Gynecology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
260
Inclusion Criteria

Not provided

Exclusion Criteria

severe fetal malformations, lethal fetal chromosomal abnormalities, and multiple pregnancies abruption of placenta, prolapse of umbilical cord, non reassuring fetal status, massive genital hemorrhage due to placenta previa, uterine rupture, and other feto-maternal emergent status

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
fetal death, neonatal and infant death, neurological development at 2 years of age (cerebral palsy, severe developmental delay)
Secondary Outcome Measures
NameTimeMethod
hospitalization in the neonatal intensive care unit, respiratory distress syndrome, artificial respiration, chronic lung disease, retinopathy of prematurity, necrotizing enterocolitis, cerebral hemorrhage, periventricular leukomalacia, visual and hearing impairment at 2 years of age
© Copyright 2025. All Rights Reserved by MedPath